Skip to main navigation Skip to search Skip to main content

PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma

  • Georgios N. Pongas
  • , Christina M. Annunziata
  • , Louis M. Staudt

Research output: Contribution to journalArticlepeer-review

Abstract

Cell line models of the activated B cell-like (ABC) subtype of diffuse large B cell (DLBCL) depend on both NF-κB and phosphatidylinositol 3-kinase (PI3K) signaling pathways for survival, especially those with gain-of-function B cell receptor (BCR) mutations. Here we show that these cells depend specifically on the PI3Kδ isoform, but that PI3K pathway interruption by PI3Kδ inhibitors is short-lived due to feedback activation of the PI3Kα isoform. PI3Kδ and PI3Kα inhibition cooperated in killing ABC DLBCL lines, and genetic knockdown of PI3Kα sensitized cells to PI3Kδ inhibition and prolonged the interruption of PI3K signaling. PI3Kδ inhibition evoked feedback activation of proximal BCR signaling, which increased the association of PI3Kα with BCAP and CD19 and increased overall PI3K activity. These results support the clinical evaluation of dual PI3Kδ and PI3Kα inhibition in patients with ABC DLBCL.

Original languageEnglish (US)
Pages (from-to)81794-81802
Number of pages9
JournalOncotarget
Volume8
Issue number47
DOIs
StatePublished - 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Pongas et al.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ABC DLBCL
  • BYL719
  • DLBCL
  • Idelalisib
  • PI3K

Fingerprint

Dive into the research topics of 'PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Cite this